Bold View Capital to Host Workshop at RESI Conference

resi conference

This year’s RESI Conference will feature a workshop from Bold View Capital!

The RESI Conference takes place September 13 – 16 and will feature a workshop on “Financing Scientific Instrumentation as a Start-Up Company”. Over the last several years, a record number of exciting life sciences start-ups have come online. Most of these start-up companies need scientific instrumentation to support their research. But when funds are limited, how can these companies get the instrumentation needed to hit their growth milestones?

Bold View Capital is hosting a workshop as part of the Service Provider Showcase at Digital RESI Conference, which takes place September 13-16. The workshop will kick-off with an overview of the leasing market for start-ups. Expert panel will share their own experiences going through the leasing process and offer valuable lessons learned.

Workshop Title: Financing Scientific Instrumentation as a Start-Up Company
Date: September 15, 2021
Time: 1:00 pm EDT
Pre-registration is required

This Financing workshop is valuable for start-up companies:

  • That rely on scientific instrumentation
  • That are pre-revenue and have limited funds to purchase instrumentation
  • For whom traditional financing is not available
  • That prefer debt financing to diluting equity

Instructors for this year’s workshop:

darren platt demetrix

Darren Platt, President, Demetrix

In addition to his strategic role as President, Darren is responsible for building our automation, computing and data platform. Prior to his work at Demetrix, he was VP of R&D at Amyris, Director of Research at 23andMe, Head of Bioinformatics at the Joint Genome Institute and Director of Bioinformatics at Exelixis. Darren received his Ph.D. in Computer Science at Monash University in Melbourne, Australia and did postdoctoral research at the Sanger Institute in Cambridge.

Bryan Leavitt, Managing Partner, Fountainhead Investment Partners

Fountainhead Investment Partners is a venture capital and private equity firm based in San Antonio, Texas. Founded by Brian Kieser in 2014, the firm focuses on investment opportunities in the medical devices, biologics, building and construction, manufacturing, industrial, and environmental industries. Our team brings considerable strategic and operational experiences into each company partnership along with our commitment to work together throughout the investment horizon.

 

chad kobold

Chad Kobold, Director of Business, Development, Bold View Capital

Chad has over 25 years of experience in the financial industry.  For the last 6 he has facilitated leasing transactions of scientific instrumentation for Bold View Capital. Chad has a unique understanding of start-ups, financing and science.

How does Bold View Capital help biotech start-up companies?

The early stages for pharmaceutical or biotech company start-ups can be a thrilling adventure, as they work on promising new drugs, or develop a new sustainable product. When a novel idea is nurtured into a viable business venture, excitement is in the air for many start-ups.

Once start-ups get their seed or series funding from their investors, the pressure to stretch every dollar can be overwhelming. When energy should be focused on improving product and growing the business, there is an equivalent pressure to preserve capital.

With pharmaceutical or biotech start-ups for example, they often need a complete workflow of analytical instrumentation for R&D and quality assurance and control purposes. When adding up all the instrumentation and consumables needed to get up and running, the final bill can be in the hundred-thousands of dollars range (if not over a million dollars).

This is where the value of financing comes into play. Acquiring analytical instrumentation via a capital or operating lease allows start-ups to preserve their capital. Instead of paying for the instrumentation all upfront, they can enter a set-term lease program with consistent, affordable monthly payments.

Learn how we help start-up companies preserve their capital, while acquiring the analytical instrumentation they need to achieve their growth milestones.

What is the RESI Conference Partnering Week?

Life Science Nation’s RESI Partnering Week takes place September 13-17, 2021, hosting three digital partnering conferences: Redefining Early Stage Investments (RESI), RESI AI, and RESI Longevity. These digital partnering conferences function as an early-stage fundraising trifecta, providing opportunities for start-ups to connect with investors and strategic partners based on product fit and stage of development. RESI has a longstanding reputation for bringing life science deal-makers together, while its AI and Longevity events host conversations for specific technology and applications, enabling attendees to customize their experience based on their needs. Each conference provides unique opportunities to buyers and sellers, and we hope you’ll join us!

Visit the RESI Conference event website to learn more and register.

SHARE:

Share on linkedin
Share on twitter
Share on facebook
Share on email